Medical Aid Funding in South Africa 2022: Medical Scheme Claims Declined in 2020 but Increased in 2021 as Members Scheduled Delayed Elective Surgeries - ResearchAndMarkets.com

2022-12-13
DUBLIN--(BUSINESS WIRE)--The "Medical Aid Funding in South Africa 2022" report has been added to ResearchAndMarkets.com's offering.
'Medical Aid Funding in South Africa 2022'
South Africa has a two-tiered, and highly unequal, healthcare system, with most of the population being state-funded. While only 14.86% of the population can afford private healthcare sector, the high costs are making it increasingly difficult for some people to continue.
Government plans to implement National Health Insurance (NHI) to fund healthcare in the public and private sectors, with most of the funding coming from general taxes and contributions of people earning above a set amount. The process, which began in August 2011, has been slow, and the NHI Bill is still under consideration in the National Assembly. The private sector has raised concerns about its affordability, and the state's ability to implement it effectively and competently.
Key Issues
Rising and unregulated healthcare costs, an ageing population and the increase in non-communicable lifestyle diseases are key challenges. Average annual consumer prices for medical services and pharmaceuticals continue to increase ahead of inflation and premiums are high, making membership unaffordable for most South Africans.
Fraud, waste, and abuse is a key issue in the industry, impacting around 22% of all claims. Fraudulent activity and abuse includes doctors and medical personnel colluding with members, submission of false claims, over-servicing or over-charging.
Trends
There has been a decrease in the number of registered medical schemes over the past two decades, mainly due to consolidation. Medical scheme membership, however, has increased. Claims declined in 2020 but increased in 2021 as members scheduled delayed elective surgeries. Changes are taking place in terms of attracting young members and low cost cover, online consultations and predictive and preventative care.
Report Coverage
This report on medical aid funding in South Africa includes information on the effects of the pandemic and recovery, membership and claims trends and the development of the NHI. There are profiles of 30 companies including the major government scheme GEMS and major private sector players such as Discovery, Momentum and Bonitas.
Key Topics Covered:
1. INTRODUCTION
2. DESCRIPTION OF THE INDUSTRY
2.1. Industry Value Chain
2.2. Geographic Position
2.3. Size of the Industry
3.1. State of the Industry
3.3. Key Issues
3.4. Notable Players
3.5. Corporate Actions
3.6. Regulations
3.7. Enterprise Development and Social Development
4. AFRICA
5. INTERNATIONAL
6. INFLUENCING FACTORS
6.2. Economic Environment
6.3. Input Costs
6.4. Fraud, Waste, and Abuse
6.5. Labour
6.6. Environmental Issues
6.7. Technology, R&D, Innovation
7.1. Competition
7.2. Ownership Structure of the Industry
7.3. Barriers to Entry
8. SWOT ANALYSIS
10. INDUSTRY ASSOCIATIONS
COMPANY PROFILES - MAJOR OPEN MEDICAL SCHEMES
Discovery Health Medical Scheme
Fedhealth Medical Scheme
KeyHealth Medical Scheme
Sizwe Hosmed Medical Scheme
COMPANY PROFILES - MAJOR RESTRICTED MEDICAL AIDS
Anglo Medical Scheme
Bankmed Medical Scheme
Chartered Accountants Medical Aid Fund
Government Employees Medical Scheme
Moto Health Care
Platinum Health Medical Scheme
Profmed Medical Scheme
SAMWU National Medical Scheme
Sasolmed Medical Scheme
South African Police Service Medical Scheme
Transmed Medical Fund
COMPANY PROFILES - MAJOR MEDICAL FUND ADMINISTRATORS
3Sixty Health (Pty) Ltd
Agility Holdings (RF) (Pty) Ltd
Discovery Health (Pty) Ltd
Metropolitan Health Corporate (Pty) Ltd
Momentum Thebe Ya Bophelo (Pty) Ltd
Professional Provident Society Healthcare Administrators (Pty) Ltd
For more information about this report visit https://www.researchandmarkets.com/r/81lv3p
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。